Republished on January 29th as another warning is issued as to the serious dangers in opening these PDFs.

Stryker beat Wall Street estimates for fourth-quarter profit and forecast 2025 earnings largely above expectations on Tuesday, fueled by strong demand for its medical and surgical devices.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Imperative Care’s Zoom System, marking an ...

Among the wave of guidance documents issued by the U.S. Food and Drug Administration (“FDA” or the “Agency”) in the first week of 2025 were ...

ClearPoint Neuro, Inc. CLPT, a global device, cell, and gene therapy-enabling company offering precise navigation to the ...

Neuralink’s brain-computer interface technology also has been discussed for other potential uses, for example, in mental ...

The website changes raise concerns about “the interference of politics with the study and the practice” of science and ...

The company states LYNX is the world’s first and only pattern scanning laser indirect ophthalmoscope and is battery-powered ...

Valencia-based Avita Medical Inc. has received FDA approval for a version of its second-generation Recell skin cell ...

If you have a microcurrent device on your wishlist, here are some benefits and drawbacks to consider before you buy one.

NeurAxis offers FDA-cleared IB-Stim device for pediatric IBS pain. Despite positive advancements, market recognition lags.

The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...